Focal Points with Brom Rector

29: Mycrodose Therapeutics Round 2: Kavalactones, Joint Venture with Thorne, Series A and more!

Listen Later

Mycrodose's CEO Chad Conner and CSO Frank Kochinke return to the podcast to tell us about:   

  • Mycrodose's partnership with Thorne  
  • How kavalactones could be used for smoking cessation and weight loss  
  • Mycrodoses DEA license to cultivate psilocybin mushrooms  
  • And more!  


    • ⭐️  Follow Mycrodose:  https://mycrodosethera.com/ 

    🔥. Follow Brom:  https://www.twitter.com/therealbrom 


    ⏰  Timestamps:  

    • 1:30 mycrodose lab in San Diego  
    • 6:00 mycrodoses’s DEA license that allows them to cultivate mushrooms  
    • 10:30 natural vs synthetic psilocybin  
    • 13:30 Mycrodose’s joint venture with Thorne 
    • 16:30 Frank’s background  
    • 20:00 - Mycrodose’s Series A  
    • 24:00 Mycrodose’s Business Model  
    • 26:00 What does the future of Mycrodose Therapeutics look like?  
    • 31:00 from Mycro to Macro  
    • 39:30 Distribution agreement with Havn Life


      • ...more
      View all episodesView all episodes
      Download on the App Store
      Focal Points with Brom RectorBy Brom Rector and Focalpoint Partners
      • 5
      • 5
      • 5
      • 5
      • 5

      5

      6 ratings

      More shows like Focal Points with Brom Rector

      View all
      Pivot by New York Magazine

      Pivot

      8,534 Listeners

      All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

      All-In with Chamath, Jason, Sacks & Friedberg

      8,385 Listeners